Inpart Logo
Campaign Preview

Allosteric SHP2 Inhibitor Programme for RAS-Driven Cancers [2026-10-01 06:41]

13 Days Left

Opportunity types being sought:

Biopharma Assets
Technologies
Research Projects
Header

Pipeline scoping test campaign content